Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today save search
Todays' Top-5
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
PALI | $5.91 19.88% 16.58% 23M
|
Manufacturing
|
| O: 39.35%
H: 18.92%
C: -13.83%
precision life collaboration
Todays' Top-5
EY Announces Jim Kras, CEO of Edible Garden AG Incorporated as an Entrepreneur Of The Year® 2024 New Jersey Award Finalist
Published: 2024-04-23 (Crawled : 13:30) - globenewswire.com
EDBL | News | $6.46 71.81% 41.8% 2M
|
|
| O: 26.61%
H: 15.92%
C: 1.85%
year award ceo
Todays' Top-5
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
TLSA | News | $0.7501 -0.46% -0.47% 2.5M
|
Health Technology
|
| O: 25.93%
H: 4.71%
C: -8.24%
fda life foralumab sclerosis sciences for program
Todays' Top-5
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
INMB | News 0 d | $10.12 -4.75% -4.99% 180K
|
Health Technology
|
| O: 19.61%
H: 1.74%
C: -2.22%
assay for commercial development
Todays' Top-5
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Published: 2024-04-23 (Crawled : 07:00) - biospace.com/
IBRX | $5.48 10.93% 9.85% 31M
|
Manufacturing
|
| O: 16.59%
H: 0.65%
C: -10.73%
il-15 anktiva fda agonist approval bladder cancer for
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
PDSB | $3.2 7.02% 6.56% 990K
|
Health Technology
|
| O: 12.36%
H: 8.33%
C: 6.67%
atile-002 versamune biotech hpv cancer key trial
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
WGS | $12.045 15.93% 13.74% 250K
|
Professional, Scientific, and T...
|
| O: 4.71%
H: 22.87%
C: 17.3%
partnership rare disease health
Volaris Reports Financial Results for the First Quarter 2024: Net Income of USD $33 million
Published: 2024-04-23 (Crawled : 02:00) - globenewswire.com
VLRS | $8.48 5.74% 0.0% 2.1M
|
Transportation
|
| O: 11.63%
H: 12.06%
C: -0.7%
million for financial results
Dime Community Bancshares, Inc. Reports First Quarter 2024 Results With Earnings Per Share Increasing By 11% Versus the Prior Quarter
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
SBNY | News | $3.5 0.0% 250K
|
Finance
|
| O: -1.43%
H: 0.0%
C: -5.22%
DCOM | $19.44 1.94% 1.9% 360K
|
Finance
|
| O: 2.94%
H: 7.69%
C: 0.94%
first results
Media Asset Revenue Generation with Veritone and Dalet
Published: 2024-04-23 (Crawled : 21:00) - veritone.com
VERI | $3.83 7.58% 7.05% 1M
|
Technology Services
|
| O: -2.25%
H: 16.38%
C: 10.06%
media revenue
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
MASS | $5.55 -0.72% -0.72% 270K
|
|
| O: 0.0%
H: 8.94%
C: -0.54%
first report financial results
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
WVE | $5.085 5.06% 4.82% 470K
|
Health Technology
|
| O: 9.62%
H: 0.97%
C: -0.97%
sirna life momentum sciences collaboration
Danaher Reports First Quarter 2024 Results
Published: 2024-04-23 (Crawled : 10:00) - prnewswire.com
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
|
| O: 8.01%
H: 0.79%
C: -0.63%
first results
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
SILO | $1.8 -9.55% -10.56% 5.2M
|
Finance and Insurance
|
| O: 9.18%
H: 0.47%
C: -16.82%
pharma positive treatment for results
Cango Inc. Announces Up to US$50 Million New Share Repurchase Program
Published: 2024-04-23 (Crawled : 10:00) - prnewswire.com
CANG | $1.33 -0.75% 0.0% 560K
|
Technology Services
|
| O: 8.21%
H: 3.45%
C: -8.28%
million repurchase program
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
AGEN A | $6.44 11.61% 10.4% 1.7M
|
Health Technology
|
| O: 7.66%
H: 30.38%
C: 12.15%
first report update financial
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
DARE | $0.306 3.62% 3.5% 320K
|
Health Technology
|
| O: 11.89%
H: 0.0%
C: -6.25%
bioscience contraceptive grant technology funding development
Ziff Davis Appoints Kate Gutman as EVP, General Manager, of its Technology Media Businesses
Published: 2024-04-23 (Crawled : 12:00) - j2global.com
ZD | $52.93 4.25% 4.08% 430K
|
Information
|
| O: -1.81%
H: 5.29%
C: 4.62%
SPOT | $303.31 11.41% 0.0% 11M
|
Technology Services
|
| O: 7.5%
H: 6.03%
C: 0.72%
CDNS S | $281.58 -1.21% -1.22% 4.5M
|
Technology Services
|
| O: -2.4%
H: 2.87%
C: 1.35%
media technology
Big 5 Sporting Goods Corporation to Report Fiscal 2024 First Quarter Results on April 30, 2024
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
BGFV 4 | $3.325 2.94% 2.86% 250K
|
Retail Trade
|
| O: 4.52%
H: 4.01%
C: 2.78%
first report corporation results
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
PHGE | $0.3465 17.42% 1.01% 220K
|
Health Technology
|
| O: 9.27%
H: 6.06%
C: 6.06%
bx004 congress treatment fibrosis for infections study
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.